Blue dye cream takes on tough skin cancer in new trial

This study tests a cream made from methylene blue, a common dye, on people with advanced basal cell carcinoma (a type of skin cancer) that cannot be treated with surgery or radiation. Twenty adults will apply the cream to their tumors every two days for one month. Researchers will measure whether the tumors shrink and how well the skin heals, with follow-up for six months. The goal is to find a safe, non-invasive option for patients who have run out of standard treatments.